An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone who’d been losing weight on semaglutide (the drug in Ozempic/Wegovy) shared that they lost almost 80 pounds over two years, then hit a long plateau of eight to nine months and even started creeping back up. They still felt strong food cravings and have about 70 pounds left to reach their goal. Their doctor is okay with their current weight, but they’ve decided to switch to tirzepatide (sold as Zepbound) to try to get unstuck, and they’re asking if others have experience with making that switch. Semaglutide is a medicine that acts like a natural gut hormone that tells your brain you’re full and slows how fast your stomach empties. That’s why people often get less hungry and eat less on it. Tirzepatide (Zepbound) is a newer drug that copies two gut hormones instead of one. In plain terms, it’s trying to do twice the signaling: one part reduces appetite and slows digestion (like semaglutide), and the other part helps control blood sugar and may enhance the feeling of fullness in another way. Both are given by injection and are prescription medications for weight management. The person’s post is an anecdote — one user’s real-world experience, not a controlled study. Clinical trials have shown tirzepatide tends to produce larger average weight losses than semaglutide for groups of people, but how any one person responds can vary a lot. Plateaus are common with weight-loss medicines: your body adjusts, and appetite can creep back. Switching drugs can sometimes kick-start more weight loss because the new drug works in a slightly different way. But an individual report doesn’t tell us how likely or how big the change will be for others. Why this matters is practical: if you’re on a medicine and it stops working as well, switching to a different approved drug might be a reasonable option to try under medical supervision. People who’ve seen good initial results but then plateau, or people whose cravings return, might be the ones most interested in switching. It’s also useful for anyone considering these drugs to know that greater weight loss reported in trials doesn’t guarantee the same outcome for every person. There are important caveats. Both drugs have side effects like nausea, diarrhea, constipation, and sometimes more serious risks that need a doctor’s oversight. Long-term effects are still being studied, and stopping the drugs often leads to weight regain unless lifestyle and other medical measures are sustained. Cost, insurance coverage, and medical eligibility differ, so a switch isn’t just a simple pharmacy swap. If someone is thinking about changing medications, they should discuss it with their healthcare provider to weigh benefits, risks, and monitoring needs. Bottom line: Switching from semaglutide to tirzepatide is a reasonable option that has worked for some people, but results vary and it should be done with medical guidance.
Source: r/Semaglutide